Consultations in Molecular Diagnostics Homozygous Transthyretin Mutation in an African

Cardiac amyloidosis of transthyretin type in the elderly may be senile or familial. The senile form is not typically associated with specific genetic changes. However, the familial form is and also occurs more frequently in African Americans than in the general population. One transthyretin mutation, V122I, is common in the African-American population, has a carrier frequency of 4%, and has marked cardiac specificity. Symptoms generally develop in the eighth and ninth decades. Here, we report the case of a 60-year-old African-American man who had a 2-year history of dyspnea and diffuse left ventricular wall thickening. Endomyocardial biopsy showed interstitial deposits of amorphous material confirmed as amyloid by Congo red staining and electron microscopy. Mass spectrometry showed a shift in protein mass of 14 d, indicative of transthyretin and confirming the production of abnormal protein. Bidirectional whole gene sequencing showed a homozygous mutation leading to a valine 122 isoleucine substitution (V122I). The 14-d mass shift observed using mass spectrometry is consistent with the V122I mutation. Homozygosity for the V122I mutation may be associated with earlier onset of cardiac disease. Transthyretin analysis should be considered for older African Americans with amyloid heart disease of transthyretin type. (J Mol Diagn 2007,

[1]  H. R. Bergen,et al.  Identification of transthyretin variants by sequential proteomic and genomic analysis. , 2004, Clinical chemistry.

[2]  D. Booth,et al.  Misdiagnosis of hereditary amyloidosis as AL (primary) amyloidosis. , 2002, The New England journal of medicine.

[3]  R. Wieczorek,et al.  Transthyretin Ile 122 and cardiac amyloidosis in African-Americans. 2 case reports. , 1997, Texas Heart Institute journal.

[4]  P. Gorevic,et al.  A homozygous transthyretin variant associated with senile systemic amyloidosis: evidence for a late-onset disease of genetic etiology. , 1990, American journal of human genetics.

[5]  W. Edwards,et al.  Amyloidosis and endomyocardial biopsy: Correlation of extent and pattern of deposition with amyloid immunophenotype in 100 cases. , 1995, Cardiovascular pathology : the official journal of the Society for Cardiovascular Pathology.

[6]  Giampaolo Merlini,et al.  Molecular mechanisms of amyloidosis. , 2003, The New England journal of medicine.

[7]  J. Kelly,et al.  Native state stabilization by NSAIDs inhibits transthyretin amyloidogenesis from the most common familial disease variants , 2004, Laboratory Investigation.

[8]  S. Thibodeau,et al.  Transthyretin Ser 6 gene frequency in individuals without amyloidosis , 1995, Human Genetics.

[9]  H. R. Bergen,et al.  An on-line assay for clinical detection of amyloidogenic transthyretin variants directly from serum , 2003, Amyloid : the international journal of experimental and clinical investigation : the official journal of the International Society of Amyloidosis.

[10]  J. Liepnieks,et al.  Senile cardiac amyloidosis associated with homozygosity for a transthyretin variant (ILE-122). , 1991, The Journal of laboratory and clinical medicine.

[11]  M. Benson,et al.  Laboratory Assessment of Transthyretin Amyloidosis , 2002, Clinical chemistry and laboratory medicine.

[12]  M. Pras,et al.  Systemic senile amyloidosis. Identification of a new prealbumin (transthyretin) variant in cardiac tissue: immunologic and biochemical similarity to one form of familial amyloidotic polyneuropathy. , 1989, The Journal of clinical investigation.

[13]  Catherine E Costello,et al.  Tabulation of human transthyretin (TTR) variants, 2003 , 2003, Amyloid : the international journal of experimental and clinical investigation : the official journal of the International Society of Amyloidosis.

[14]  Jorge Ghiso,et al.  Inclusion body myositis, muscle blood vessel and cardiac amyloidosis, and transthyretin Val122Ile allele , 2000, Annals of neurology.

[15]  J. Buxbaum,et al.  Variant-sequence transthyretin (isoleucine 122) in late-onset cardiac amyloidosis in black Americans. , 1997, The New England journal of medicine.